Overall, our results suggest that de novo DNMT activity is primarily targeted to H3K36me3 marked CGIs irrespective of the DNMT responsible but support a model in which the bulk of the de novo DNMT activity at H3K36me3 marked CGIs is dependent of DNMT3B in colorectal cancer cells. This evidence concerns the gene DNMT1 and colorectal cancer.